Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Admilparant meets primary endpoint at 60 mg dose in Phase 3 ALOFT-IPF trial for idiopathic pulmonary fibrosis


Teva’s Weltruza becomes first once monthly subcutaneous olanzapine injection to win FDA approval for adults with schizophrenia


Regeneron’s Pasatru shows no new bone lesions in adult FOP patients between weeks 56 and 84 of OPTIMA


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Next generation processes: What model works the best in Asia?

Presented by Ravishankar Kasturi, Vice President, Head of Manufacturing & Process Development, Reliance Life Sciences and Britta Manser, Scientist Continuous Bioprocessing
11th September 2018


From Product Characterization to Clinical Reliable Specifications

Presented by André Mischo, Associate Director Science & Technology at Novartis
11th May 2022


Applications of industry 4.0 concepts in continuous pharmaceutical tablet manufacturing process

Presented by Dr Ravendra Singh, Research Faculty at C-SOPS, Department of Chemical and Biochemical Engineering, Rutgers University, NJ, USA
27th January 2022


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia